These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9641731)

  • 1. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Fjellestad-Paulsen A; Czernichow P; Brauner R; Bost M; Colle M; Lebouc JY; Lecornu M; Leheup B; Limal JM; Raux MC; Toublanc JE; Rappaport R
    Acta Paediatr; 1998 May; 87(5):511-7. PubMed ID: 9641731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Czernichow P; Fjellestad-Paulsen A
    Horm Res; 1998; 49 Suppl 2():23-7. PubMed ID: 9730668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up height after discontinuation of growth hormone treatment in children with intrauterine growth retardation.
    Darendeliler F; Bundak R; Eryilmaz SK; Günöz H; Baş F; Saka N
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):795-800. PubMed ID: 12099389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset.
    Job JC; Chaussain JL; Job B; Ducret JP; Maes M; Olivier M; Ponte C; Rochiccioli P; Vanderschueren-Lodeweyckx M; Chatelain P
    Pediatr Res; 1996 Feb; 39(2):354-9. PubMed ID: 8825812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.
    Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children.
    Coutant R; Carel JC; Letrait M; Bouvattier C; Chatelain P; Coste J; Chaussain JL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1070-4. PubMed ID: 9543119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height of patients treated for isolated GH deficiency: examination of 83 patients.
    Cacciari E; Cicognani A; Pirazzoli P; Zucchini S; Salardi S; Balsamo A; Cassio A; Pasini A; Carlá G; Tassinari D; Gualandi S
    Eur J Endocrinol; 1997 Jul; 137(1):53-60. PubMed ID: 9242202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S; Street ME; Volta C; Mazzardo G
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years.
    de Zegher F; Butenandt O; Chatelain P; Albertsson-Wikland K; Jonsson B; Löfström A; Chaussain JL
    Acta Paediatr Suppl; 1997 Nov; 423():207-12. PubMed ID: 9401574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone treatment of children with short stature secondary to intra-uterine growth retardation: effect of 2 years' treatment and 2 years' follow-up.
    Rosilio M; Carel JC; Blazy D; Chaussain JL
    Horm Res; 1997; 48 Suppl 4():23-8. PubMed ID: 9350442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency.
    Smuel K; Kauli R; Lilos P; Laron Z
    Growth Horm IGF Res; 2015 Aug; 25(4):182-8. PubMed ID: 26077773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.
    Hertel NT; Eklöf O; Ivarsson S; Aronson S; Westphal O; Sipilä I; Kaitila I; Bland J; Veimo D; Müller J; Mohnike K; Neumeyer L; Ritzen M; Hagenäs L
    Acta Paediatr; 2005 Oct; 94(10):1402-10. PubMed ID: 16299871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human growth hormone in short children born small for gestational age. German Study Group.
    Butenandt O; Lang G
    J Pediatr Endocrinol Metab; 1997; 10(3):275-82. PubMed ID: 9388818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver syndrome.
    Azcona C; Albanese A; Bareille P; Stanhope R
    Horm Res; 1998; 50(1):22-7. PubMed ID: 9691209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult height.
    van Gool SA; Kamp GA; Odink RJ; de Muinck Keizer-Schrama SM; Delemarre-van de Waal HA; Oostdijk W; Wit JM
    Eur J Endocrinol; 2010 Apr; 162(4):653-60. PubMed ID: 20110402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.